[1]穆杰,鲁法庭,王东,等.基于网络药理学与“以药测证”挖掘非酒精性脂肪性肝病的证型、治法与方药[J].西部中医药,2025,38(03):1-9.[doi:10.12174/j.issn.2096-9600.2025.03.01]
　MU Jie,LU Fating,WANG Dong,et al.The Syndromes, Therapeutic Method and Prescriptions of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and "Syndrome Differentiation by Effect of Drugs"[J].Western Journal of Traditional Chinese Medicine,2025,38(03):1-9.[doi:10.12174/j.issn.2096-9600.2025.03.01]
点击复制

基于网络药理学与“以药测证”挖掘非酒精性脂肪性肝病的证型、治法与方药()

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
38
期数:
2025年03期
页码:
1-9
栏目:
基础研究
出版日期:
2025-03-15

文章信息/Info

Title:
The Syndromes, Therapeutic Method and Prescriptions of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and "Syndrome Differentiation by Effect of Drugs"
作者:
穆杰, 鲁法庭, 王东, 苏悦, 刘西洋, 冯全生
成都中医药大学，四川 成都 611137
Author(s):
MU Jie, LU Fating, WANG Dong, SU Yue, LIU Xiyang, FENG Quansheng
Chengdu University of TCM, Chengdu 611137, China
关键词:
非酒精性脂肪性肝病; 网络药理学; 反向药靶; 以药测证
Keywords:
nonalcoholic fatty liver disease; network pharmacology; reversed herbal targets; syndrome differentiation by effect of drug
分类号:
R256.4
DOI:
10.12174/j.issn.2096-9600.2025.03.01
文献标志码:
A
摘要:
目的探讨非酒精性脂肪性肝病（nonalcoholic fatty liver disease，NAFLD）的证机、治法、方药，并验证预测的中药复方的有效性。 方法采用靶点数据集建立蛋白质-蛋白质相互作用（protein-protein interactions，PPI）网络、拓扑分析、反向药靶关系检索等方法，探讨NAFLD证型、方药。另将24只Wistar大鼠分为空白组（正常饲养）、高脂饮食组（high-fat diet，HFD）（给予高脂饲料）和中药组（在高脂饲料基础上以中药灌胃），每组8只，4周后检测体质量、肝质量、肝指数、内脏脂肪质量、体脂率、血清生化等，评价预测处方对NAFLD的治疗作用。 结果采用反向药靶关系网络预测、分析出NAFLD主要涉及14种不同的证型，可以将桑叶、金银花、沙棘、银杏叶、葛花作为底方，参考16种中药类别而选择药物，实验研究显示预测处方能够显著改善NAFLD病理。HFD组相较空白组大鼠体质量、肝重、肝指数、内脏脂肪质量、体脂率、血清谷草转氨酶（aspartate aminotransferase，AST）、谷丙转氨酶（alanine aminotransferase，ALT）、甘油三酯（triglyceride，TG）、总胆固醇（total cholesterol，TC）、游离脂肪酸（free fatty acid，FFA）及肝组织TG含量均升高（P＜0.01），且中药组相较HFD组体质量、肝重、肝指数、内脏脂肪质量、体脂率、血清AST、ALT、TG、TC、FFA及肝组织TG含量均降低（P＜0.05）；HFD组相较空白组肝组织TG含量升高（P＜0.01），病理切片显示肝内出现显著的气球样变、炎症细胞聚集及部分肝细胞坏死。 结论NAFLD主要与热、毒、风、痰、瘀、湿相关，涉及了14种不同的证型，治疗以清热、解毒、化痰、止痛、健脾、祛风立法，且结合动物实验验证了桑叶、金银花、沙棘、银杏叶、葛花为底方对NAFLD的治疗效果。
Abstract:
ObjectiveTo survey the pathogenesis, therapeutic methods and prescriptions of nonalcoholic fatty liver disease (NAFLD), and to verify the effectiveness of the predicted Chinese medicine compound. MethodsProtein-protein interaction (PPI), topology analysis and reversed herbal targets established by therapeutic targets database (TTD), were explored to discuss the pathogenesis and prescriptions of NAFLD. Male adult Wistar rats were employed as the subjects in the experiment, all 24 Wistar rats were allocated to the blank group, HFD group and herb group (n=8), the predicted therapeutic effects of the prescription on NAFLD were assessed by detecting body mass, liver weight, liver index, visceral fat mass, body fat percentage and serum biochemical examination. ResultsReverse drug target network was adopted to predict and analyze 14 syndromes of NAFLD, Sangye (Mori folium), Jinyinhua (Lonicerae japonicae flos), Shaji (Hippophae fructus), Yinxingye (Ginkgo Folium) and Gehua (Flower of lobed Kudzuvine) were used as the based prescription, 16 herbal categories were consulted and chosen according to the symptoms, the experiments displayed that the predicted prescription could noticeably improve the pathology of NAFLD. When HFD group was compared with the blank group, body mass, liver weight, liver index, visceral fat mass, body fat percentage, and the contents of AST, ALT, TG, TC, FFA and TG in liver tissue were elevated (P<0.01), the decrease in body mass, liver weight, liver index, visceral fat mass, body fat percentage, and the contents of AST, ALT, TG, TC, FFA and TG in liver tissue was more evident in the herb group compared with HFD group (P<0.05); the content of TG was higher in HFD group than that of the blank group (P<0.01), pathological section showed significant balloon-like changes, inflammatory cell aggregation and partial hepatocyte necrosis in the liver. ConclusionNAFLD is mainly related to heat, toxin, wind, phlegm, stasis and dampness, involving 14 various syndromes, treated with the methods of clearing heat, detoxifying, resolving phlegm, relieving pain, invigorating spleen and dispelling wind, and animal experiments have been conducted to verify the therapeutic effects of Sangye, Jinyinhua, Shaji, ginkgo and Gehua as the base prescription for NAFLD.

相似文献/References:

[1]范小芬,邓银泉,陈玖,等.非酒精性脂肪性肝病不同中医证型与血清TNF-α、IL-6水平的关系研究[J].西部中医药,2016,29(01):5.
　FAN Xiaofen,DENG Yinquan,CHEN Jiu,et al.Study on the Relationship between Different Patterns of Nonalcoholic Fatty Liver Disease and the Levels of TNF-α and IL-6[J].Western Journal of Traditional Chinese Medicine,2016,29(03):5.
[2]刘新宇,陈星宇,毕鸿昊,等.基于网络药理学和分子对接探讨枸杞子-菟丝子-当归治疗视网膜色素变性的作用机制[J].西部中医药,2025,38(12):79.[doi:10.12174/j.issn.2096-9600.2025.12.16]
　LIU Xinyu,CHEN Xingyu,BI Honghao,et al.Exploring the Mechanism of Action of Gouqizi-Tusizi-Angelica in the Treatment of Retinitis Pigmentosa Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(03):79.[doi:10.12174/j.issn.2096-9600.2025.12.16]
[3]赵靖昌,丛超,吴盼晴,等.基于网络药理学和分子对接技术探讨开郁种玉汤治疗非器质性女性不孕症的机制[J].西部中医药,2026,39(01):45.[doi:10.12174/j.issn.2096-9600.2026.01.10]
　ZHAO Jingchang,CONG Chao,WU Panqing,et al.Mechanism of Qi Stagnation-relieving Offspring-generating Decoction in the Treatment of Non-organic Female Infertility: Network Pharmacology and Molecular Docking Technology[J].Western Journal of Traditional Chinese Medicine,2026,39(03):45.[doi:10.12174/j.issn.2096-9600.2026.01.10]
[4]杨雅婷,李宝玲,徐春悦,等.归脾汤基于肠道菌群治疗血管性痴呆的网络药理学研究[J].西部中医药,2026,39(01):79.[doi:10.12174/j.issn.2096-9600.2026.01.15]
　YANG Yating,LI Baoling,XU Chunyue,et al.Network Pharmacology-based Study on Guipi Decoction in Treating Vascular Dementia Based on Gut Microbiota[J].Western Journal of Traditional Chinese Medicine,2026,39(03):79.[doi:10.12174/j.issn.2096-9600.2026.01.15]
[5]田颢颐,田耘.基于网络药理学方法探讨活血药治疗IgA肾病的作用机制[J].西部中医药,2026,39(01):87.[doi:10.12174/j.issn.2096-9600.2026.01.16]
　TIAN Haoyi,TIAN Yun.Network Pharmacology-based Exploration into the Mechanism of Blood-activating Drugs in the Treatment of IgA Nephropathy[J].Western Journal of Traditional Chinese Medicine,2026,39(03):87.[doi:10.12174/j.issn.2096-9600.2026.01.16]
[6]李晓彤,李家立,曹志群,等.基于网络药理学和分子对接技术探讨参苓白术散治疗功能性腹泻的作用机制[J].西部中医药,2026,39(01):96.[doi:10.12174/j.issn.2096-9600.2026.01.17]
　LI Xiaotong,LI Jiali,CAO Zhiqun,et al.Mechanism of Shenling Baizhu Powder in Treating Functional Diarrhea Based on Network Pharmacology and Molecular Docking Technology[J].Western Journal of Traditional Chinese Medicine,2026,39(03):96.[doi:10.12174/j.issn.2096-9600.2026.01.17]
[7]王嘉宁,王健.基于数据挖掘和网络药理学方法探讨惊恐障碍的中药治疗机制[J].西部中医药,2026,39(01):107.[doi:10.12174/j.issn.2096-9600.2026.01.18]
　WANG Jia?ning,WANG Jian.Mechanism of TCM Treatment for Panic Disorder Based on Data Mining and Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2026,39(03):107.[doi:10.12174/j.issn.2096-9600.2026.01.18]
[8]偶勇,古娜,晁旭.基于网络药理学探讨黄芪-莪术治疗肝癌的作用机制[J].西部中医药,2026,39(01):129.[doi:10.12174/j.issn.2096-9600.2026.01.21]
　OU Yong,GU Na,CHAO Xu.Network Pharmacology-based Exploration into the Mechanism of Huangqi-Ezhu in Treating Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2026,39(03):129.[doi:10.12174/j.issn.2096-9600.2026.01.21]
[9]韩燕鸿,李君,潘建科,等.基于网络药理学方法探讨丹参-牡丹皮配伍治疗膝骨性关节炎的作用机制[J].西部中医药,2026,39(01):65.[doi:10.12174/j.issn.2096-9600.2026.01.13]
　HAN Yanhong,LI Jun,PAN Jianke,et al.Network Pharmacology-based Discussion on the Mechanism of Danshen-Mudanpi Combination in Treating Knee Osteoarthritis[J].Western Journal of Traditional Chinese Medicine,2026,39(03):65.[doi:10.12174/j.issn.2096-9600.2026.01.13]
[10]黄小芮,刘建华,闫占峰,等.基于网络药理学与分子对接探讨苓桂术甘汤治疗良性阵发性位置性眩晕的机制[J].西部中医药,2026,39(03):108.[doi:10.12174/j.issn.2096-9600.2026.03.21]
　HUANG Xiaorui,LIU Jianhua,YAN Zhanfeng,et al.Network Pharmacology and Molecular Docking Based Exploration into the Mechanism of Lingguizhugan Decoction in the Treatment of Benign Paroxysmal Positional Vertigo[J].Western Journal of Traditional Chinese Medicine,2026,39(03):108.[doi:10.12174/j.issn.2096-9600.2026.03.21]

备注/Memo

备注/Memo:
穆杰（1990—），男，博士学位，硕士研究生导师，副教授。研究方向：中医辨证论治理论体系、经方治疗常见病疑难病、经方配伍规律与作用机制及临床应用研究。四川省青年基金项目（2024NSFSC1829，2025ZNSFSC1795）；成都市卫生健康委员会联合创新专项（WXLH202402052）；成都中医药大学青基人才专项（QJRC2024002）。
更新日期/Last Update: 2025-03-15